PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsNitazoxanide
Nitazoxanide
Nitazoxanide (nitazoxanide) is a small molecule pharmaceutical. Nitazoxanide was first approved as Alinia on 2002-11-22. It is used to treat cryptosporidiosis, diarrhea, giardiasis, and protozoan infections in the USA.
Download report
Favorite
COVID-19
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
digestive system diseasesD004066
animal diseasesD000820
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
Nitazoxanide (discontinued: Alinia)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Nitazoxanide
Tradename
Company
Number
Date
Products
ALINIARomark Laboratories L.c.N-021497 DISCN2004-07-21
1 products, RLD
ALINIARomark Laboratories L.c.N-021498 DISCN2002-11-22
1 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
aliniaNew Drug Application2024-03-20
nitazoxanideANDA2025-03-05
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
P: Antiparasitic products, insecticides and repellents
P01: Antiprotozoals
P01A: Agents against amoebiasis and other protozoal diseases
P01AX: Other agents against amoebiasis and other protozoal diseases in atc
P01AX11: Nitazoxanide
HCPCS
No data
Clinical
Clinical Trials
110 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HepatitisD006505K75.9717
Hepatitis aD006506EFO_0007305B15717
Hepatitis cD006526B19.2616
Chronic hepatitis cD019698EFO_0004220B18.2616
Chronic hepatitisD006521K73.9515
Covid-19D000086382U07.155
Human influenzaD007251EFO_0007328J11.1245
EnterovirusD00477022
RhinovirusD01222922
Enterovirus infectionsD004769EFO_0007255B34.122
Show 11 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hepatitis bD00650911
Chronic hepatitis bD019694EFO_0004239B18.111
GastroenteritisD005759EFO_1001463K52.911
Clostridioides difficileD016360NCBITaxon_149611
ColitisD003092EFO_0003872K52.911
Crohn diseaseD003424EFO_0000384K5011
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameNitazoxanide
INNnitazoxanide
Description
Acetic acid [2-[[(5-nitro-2-thiazolyl)amino]-oxomethyl]phenyl] ester is a carboxylic ester and a member of benzamides. It is functionally related to a salicylamide.
Classification
Small molecule
Drug classantiparasitics (salicylanilide derivatives)
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1
Identifiers
PDB
CAS-ID55981-09-4
RxCUI
ChEMBL IDCHEMBL1401
ChEBI ID
PubChem CID41684
DrugBankDB00507
UNII IDSOA12P041N (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
£
No data
Estimated US medical usage
Nitazoxanide
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 4,672 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
497 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use